The Library
Identification of a novel corticotropin-releasing hormone type 1 beta-Like receptor variant lacking exon 13 in human pregnant myometrium regulated by estradiol-17 beta and progesterone
Tools
Tools
Tools
Karteris, Emmanouil, Markovic, Danijela, Chen, Jing, Hillhouse, Edward W. and Grammatopoulos, Dimitris (2010) Identification of a novel corticotropin-releasing hormone type 1 beta-Like receptor variant lacking exon 13 in human pregnant myometrium regulated by estradiol-17 beta and progesterone. Endocrinology, Vol.151 (No.10). pp. 4959-4968. doi:10.1210/en.2010-0622
Research output not available from this repository, contact author.
Official URL: http://dx.doi.org/10.1210/en.2010-0622
Abstract
Two types of CRH receptors mediate the diverse biological functions of CRH and CRH-related peptides. The type 1 CRH-R (CRH-R1) is extensively targeted by pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants. RT-PCR amplification of CRH-R1 sequences from human myometrium yielded cDNAs that encode a novel CRH-R1 splice variant with structural characteristics identical with CRH-R1 beta except a 14-amino acid deletion in the seventh transmembrane domain characteristic of the CRH-R1d. Transient expression of the hybrid CRH-R1 variant (CRH-R1 beta/d) in human embryonic kidney 293 cells revealed primarily intracellular expression, although some plasma membrane protein expression was also detectable. CRH bound to CRH-R1 beta/d with affinity comparable with the CRH-R1 beta; however, it was unable to stimulate adenylyl cyclase or other second messengers. Using a semiquantitative RT-PCR assay, CRH-R1 beta/d mRNA transcript was detected in human pregnant, but not nonpregnant, myometrium as early as 31 wk of gestation. Furthermore, in human pregnant myometrial cells, the relative expression of CRH-R1 beta and CRH-R1 beta/d mRNA appeared to be regulated by steroids; CRH-R1 beta/d mRNA expression was increased by estradiol-17 beta, whereas CRH-R1 beta mRNA levels were increased by progesterone. Progesterone also substantially increased CRH-R1 alpha mRNA levels and cellular responsiveness to CRH as determined by increased agonist binding and cAMP production as well as resistance to CRH-R heterologous desensitization by phorbol esters. These results provide novel evidence for distinct patterns of CRH-R1 splicing and identify specific steroid-mediated regulation of CRH-R1 variant expression, which might be important for modulating CRH actions during human pregnancy and labour. (Endocrinology 151: 4959-4968, 2010)
| Item Type: | Journal Article | ||||
|---|---|---|---|---|---|
| Subjects: | R Medicine > RC Internal medicine | ||||
| Divisions: | Faculty of Medicine > Warwick Medical School | ||||
| Journal or Publication Title: | Endocrinology | ||||
| Publisher: | The Endocrine Society | ||||
| ISSN: | 0013-7227 | ||||
| Official Date: | October 2010 | ||||
| Dates: |
|
||||
| Volume: | Vol.151 | ||||
| Number: | No.10 | ||||
| Number of Pages: | 10 | ||||
| Page Range: | pp. 4959-4968 | ||||
| DOI: | 10.1210/en.2010-0622 | ||||
| Status: | Peer Reviewed | ||||
| Publication Status: | Published | ||||
| Access rights to Published version: | Restricted or Subscription Access | ||||
| Funder: | Wellcome Trust |
Data sourced from Thomson Reuters' Web of Knowledge
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
